Publications dans lesquelles il/elle collabore avec Jorge Cannata Andía (12)

2023

  1. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

    Nutrients, Vol. 15, Núm. 13

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2019

  1. Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients

    Nefrologia, Vol. 38, Núm. 5, pp. 520-527

2017

  1. Regulation of miR-29b and miR-30c by vitamin D receptor activators contributes to attenuate uraemia-induced cardiac fibrosis

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 11, pp. 1831-1840

2016

  1. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

    Kidney International, Vol. 90, Núm. 1, pp. 77-89

  2. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load

    Bone, Vol. 84, pp. 160-168

2015

  1. Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk

    Medicine (United States), Vol. 94, Núm. 30

2013

  1. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733

2011

  1. Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis

    Toxicological Sciences, Vol. 122, Núm. 1, pp. 73-85

2010

  1. Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency

    Menopause, Vol. 17, Núm. 4, pp. 766-771

  2. New therapies: Calcimimetics, phosphate binders and vitamin D receptor activators

    Pediatric Nephrology